← Leaderboards
Sandra L Fowler
Medical University Of South Carolina
$90,984
Attributed
$90,984
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3K · FY2007–08$5K$3.8K$2.5K$1.3K$0
'07
'08
Funding mix
By agency
NIH$90,984 · 7
By mechanism
M01$90,984 · 7
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Arch G Mainous$2,206,087
- Alexander V Alekseyenko$2,205,771
- Kathleen Theresa Brady$137,017,915
- Steven D London$7,076,044
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationDrug Screening /EvaluationHuman SubjectMicroorganism Disease ChemotherapyAntiviral AgentsGenital HerpesComputer Retrieval Of Information On Scientific Projects DatabaseGrantAthleticHerpes Simplex DiseaseCommunitiesFamilyBacteriaHerpes Simplex Virus 2Drug Adverse EffectBone And BonesBody SurfaceDisease OutbreaksFundingFurunclesAntibioticsHeart ValvesHousehold
Grant awards (7)
SITE OF COMMUNITY ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS COLONIZA$775
M01 · FY2008 · RR · contact PI
SITE OF COMMUNITY ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS COLONIZA$3,033
M01 · FY2007 · RR · contact PI
SAFETY AND EFFICACY OF FAMCICLOVIR OR VALACICLOVIR FOR PRIMARY GENITAL HERPES$17,441
M01 · FY2000 · RR
EFFICACY OF HERPES SIMPLEX CANDIDATE VACCINE WITH MPL$17,441
M01 · FY2000 · RR
SB 209763 RSV INFECTION PROPHYLAXIS$17,441
M01 · FY2000 · RR
SAFETY OF HERPES SIMPLEX CANDIDATE VACCINE IN HSV SEROPOS/SERONEG SUBJECTS$17,441
M01 · FY2000 · RR
Genital herpes$17,412
M01 · FY2000 · RR